Phytochemistry Reviews Биотехнология

Phytosome-based drug delivery systems: an updated patent review

Mukhopadhyay, Shibangi, Agrawal, Nidhi, Biswas, Jaishree, Bharat, Vaishali, Lanjhiyana, S. K., Bharti, Sanjay Kumar, Jaiswal, Meenakshi
Springer Nature · 2026-10-01 · DOI 10.1007/s11101-026-10295-x

Аннотация

Phytosomes are lipid-based carrier systems that enhance solubility, stability, and bioavailability of poorly absorbed phytochemicals. Patent analysis revealed that only 35 patents between the year 2000-2024. Patent trends showed significant growth after 2010. 16 plant extracts and several pure compounds were frequently patented. Patented phytosome formulations targeted 18 disease domains. Granted patent highlighted innovations such as nano scale phytosome, self-microemulsion systems and polyphenol loaded phytosome. Plant-derived compounds known as phytochemicals have various therapeutic benefits in terms of human health. Despite the wide range of therapeutic uses of phytochemicals, they are encountered with many challenges, viz., poor solubility, instability, and reduced bioavailability in a few instances. Many researchers have recently used phytosomes to overcome these technical difficulties and achieve better outcomes. A phytosome is a matrix-carrier system composed of active phytochemical(s) and phospholipids that enhances the absorption and bioavailability of phytochemicals while facilitating the transport of medication to the target site of action. Globally, the increase in patent registrations over the last two decades has demonstrated a significant growing interest in utilizing phytosomes for developing medicines and nutraceuticals. This report presents a thorough investigation of patents registered regarding phytosomes from the years 2000 to 2024, aiming to detail technological advancements, methodological developments, applications for specific diseases, therapeutic domains, and nutraceuticals in a coherent sequence. The expanding patent landscape on phytosome-based formulations underscores their promise in enhancing bioavailability, targeted delivery, and therapeutic efficacy of natural compounds in comparison to synthetic active compounds. However, future success will rely on bridging preclinical innovation with robust clinical validation and addressing regulatory challenges for translational acceptance. Graphical abstract

Читать у издателя →